The Fully Automatic Filling Equipment Was Officially Put Into Production, And The Efficient Improvement Of Production Capacity Helped Promote The High-Quality Development Of Biological Research

March 24, 2025 · Chengdu

Oriscience Biotechnology (Chengdu) Co., Ltd. (hereinafter referred to as "Oriscience") announced that the fully automatic filling production line introduced in 2024 has been officially put into operation. The commissioning of this equipment marks that the company's production efficiency has entered a new stage of intelligence, and the production capacity of core products has been efficiently improved, providing customers with more efficient and stable scientific research reagent solutions.

1. Technology upgrade: Automation enables precise production

The newly invested fully automatic filling equipment adopts the world's leading aseptic filling technology to realize the automation of the entire process from subpackaging to sealing, and the error rate of key links is reduced to below 0.01%. Compared with traditional production lines, the new equipment has the following advantages:

Efficiency improvement: Improved accuracy and stability to meet the needs of large-scale orders.

Quality assurance: Through real-time data monitoring, ensure that the filling accuracy meets the standards.

2. Capacity Leap: Respond to market demand and accelerate product delivery

As the global biopharmaceutical market continues to expand, Oriscience's upgrade is aimed at solving the industry's "capacity bottleneck" pain point. After the new production line is put into production, the average delivery cycle of customer orders will be shortened by 50%.

3. Strategic layout: driving the development of the entire industry chain with innovation

Xu Xiaochao, general manager of Oruiss, said: "Fully automatic filling equipment is a key step in the company's 'Smart Manufacturing 2025' strategy. In the next three years, we will continue to invest in intelligent manufacturing and green production technologies to achieve comprehensive coverage of conventional products in the field of scientific services."

4. About Oruiss Biotechnology (Chengdu) Co., Ltd.

Since its establishment, Oruiss Biotechnology (Chengdu) Co., Ltd. has always been committed to providing efficient services for scientific research and production. The company adheres to the four major service concepts of "high quality, good price, localization, and customization", focusing on several key areas such as molecules, proteins, immunity and cells, and providing high-quality reagent products.

Through years of technical accumulation and talent reserves, a research and development team with continuous innovation capabilities has been established, realizing independent research and development and production of all products. In the future, we will continue to deepen our efforts in the field of biological sciences, continue to develop and produce more high-quality biological reagents, and provide better experimental solutions for biological research customers.